Skip to content

Disc Medicine

US · IRON #2647 by market cap Listed 1970
75.14 -0.97 -1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 9 in the most recent period (2026/Q3).
  • Total institutional ownership fell 18.6 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
103.59% -18.57pp
Institutions
285 +9
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund52.11%
VC/PE Fund25.11%
Hedge Fund20.94%
Private Company3.07%
Public Company1.39%
Individual/Insider0.48%
Government Pension Fund0.28%
Endowment Fund0.28%
Insurance Company0.24%
Sovereign Wealth Fund0.24%

Top holders as of 2026-09-30

FMR 10.55% · 4.80M sh
Access Industries, Inc. 6.02% · 2.74M sh
BlackRock 5.56% · 2.53M sh
RA Capital Management, L.P. 5.38% · 2.45M sh
T. Rowe Price Group, Inc. 4.12% · 1.88M sh
J.P. Morgan Asset Management, Inc. 4.03% · 1.84M sh
Wellington Management Group 3.82% · 1.74M sh
Vestal Point Capital, LP 3.40% · 1.55M sh
Atlas Venture Advisors, Inc. 3.11% · 1.42M sh
Vanguard Capital Management, LLC 3.59% · 1.59M sh
State Street Global Advisors 3.09% · 1.41M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 20 buys · 30 sells

NameRoleStake
John Quisel Chief Executive Officer 0.25%
William Savage Chief Medical Officer 0.08%
Pamela Stephenson Chief Commercial Officer 0.04%
Rahul Khara Chief Legal Officer 0.04%
Donald Nicholson Executive Chairperson 0.03%
Jonathan Yu Chief Opearating Officer 0.02%
Joanne Bryce Former Chief Financial Officer 0.01%
Atlas Venture Advisors, Inc. -- --
OrbiMed Advisors LLC -- --
Access Industries, Inc. -- --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-09 William Savage Chief Medical Officer Automatic Disposition -16,035 $85.09
2026-10-20 Atlas Venture Advisors, Inc. -- Automatic Disposition -41,825 $79.95–80.23
2026-09-14 John Quisel Chief Executive Officer Derivative Exercise and Retained +36,000 $1.01
2026-09-10 Kevin Bitterman Independent Director Derivative Exercise and Sale -27,136 $38.85–70.11
2026-09-03 Atlas Venture Advisors, Inc. -- Automatic Disposition -1,689 $79.96
2026-09-02 Atlas Venture Advisors, Inc. -- Automatic Disposition -54,496 $79.95–80.98
2026-08-24 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -9,096 $13.50–83.12
2026-08-16 John Quisel Chief Executive Officer Derivative Exercise and Sale -33,000 $13.50–79.84
2026-08-11 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -804 $13.50–82.64
2026-08-05 Rahul Khara Chief Legal Officer Derivative Exercise and Sale -5,000 $14.69–80.00
2026-07-12 John Quisel Chief Executive Officer Derivative Exercise and Sale -33,000 $9.86–76.05
2026-07-06 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -100 $13.50–82.50
2026-06-28 Rahul Khara Chief Legal Officer Derivative Exercise and Sale -2,500 $14.69–75.00
2026-06-25 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -300 $13.50–72.50
2026-06-21 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -9,700 $13.50–72.66
2026-06-17 Georges Gemayel Independent Director Other Derivative Acquisition +6,212 $70.79
2026-06-17 Kevin Bitterman Independent Director Other Derivative Acquisition +6,212 $70.79
2026-06-17 Liam Ratcliffe Independent Director Other Derivative Acquisition +6,212 $70.79
2026-06-17 John Quisel Chief Executive Officer Derivative Exercise and Sale -34,000 $9.86–71.61
2026-06-17 Mark Chin Independent Director Other Derivative Acquisition +6,212 $70.79

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:01:18 · For reference only, not investment advice and not tailored to your situation.

Disc Medicine discussion 0 comments

Add a comment